COMMUNIQUÉS West-GlobeNewswire

BioCryst Launches ORLADEYO® (berotralstat) in Italy
19/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized [...]
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa [...]
Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
19/02/2024
ORION CORPORATION PRESS RELEASE 19 FEBRUARY 2024 at 13:15 EET Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland Orion Corporation is evaluating the possible outsourcing of [...]
Transactions in connection with share buy-back program
19/02/2024
Company Announcement COPENHAGEN, Denmark; February 19, 2024 – Genmab A/S (Nasdaq: GMAB). On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted [...]
New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses
19/02/2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone. A new global commercial partnership between Boehringer Ingelheim and Sleip will expand access [...]
GN Store Nord A/S - Notice to convene the Annual General Meeting 2024
19/02/2024
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 13, 2024, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark. Please find attached the notice to convene the Annual [...]
Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis
19/02/2024
MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces [...]
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa [...]
BioPorto A/S to host investor meetings on 22 February 2024
19/02/2024
19 February 2024 News Release BioPorto A/S to host investor meetings on 22 February 2024 COPENHAGEN, DENMARK and BOSTON, Mass., 19 February 2024, BioPorto A/S (BioPorto or Company), an in vitro diagnostics company [...]
Vidac Pharma presents high efficacy in multiple solid tumor models for its next-generation cancer drug candidate and synergy with standard-of-care treatment in liver cancer organoids
19/02/2024
London (UK), February 19, 2024, 7:30 am CET – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of [...]
Vidac Pharma présente une efficacité élevée dans plusieurs modèles de tumeurs solides pour son candidat médicament anticancéreux de nouvelle génération, et une synergie avec le traitement standard des organoïdes du cancer du foie
19/02/2024
Londres (Royaume-Uni), 19 février 2024, 7:30 CET – Vidac Pharma Holding Plc (Hambourg et Stuttgart : T9G ; ISIN : GB00BM9XQ619 ; WKN : A3DTUQ) est une société biopharmaceutique d'oncologie de stade clinique, pionnière [...]
Ultimovacs Receives EMA Orphan Drug Designation for UV1 Cancer Vaccine for the Treatment of Mesothelioma
19/02/2024
The Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) was granted based on results from the randomized Phase II clinical trial NIPU, which showed improved overall survival with UV1 in combination [...]
CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty
19/02/2024
CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty Clermont-Ferrand, France, 19 February 2024 (06.45am [...]
CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique
19/02/2024
CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique Clermont- [...]
New report exposes harmful impact of Ford government’s privatization scheme on local public hospitals: Health Coalition
18/02/2024
TORONTO, Feb. 18, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department wait times, burgeoning deficits, and an unrelenting staffing crisis, it is running high- [...]
Nordic Naturals Issues Voluntary Recall of Baby's Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3
17/02/2024
WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl. oz. (22.5 mL), 400 IU (10mcg) D3. This recall is being [...]
BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS
17/02/2024
CEO, Groovy Singh appointed as a new member of the Company’s Board Founder, Lynn Stockwell, appointed as Chair of the Board of Directors Grants, New Mexico, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation ( [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16/02/2024
SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
R1 RCM to Present at Upcoming Investor Conferences
16/02/2024
MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today [...]

Pages